We could see a new robotic surgery instrument from Intuitive Surgical, Inc. (ISRG) before the end of this year, according to J.P. Morgan Analyst Tycho Peterson. He said the company filed for a trademark on a news system and that finished goods inventories went up last quarter.
“There are some subtle signs that things could be moving in the direction of a new system launch,” Peterson says. “Overall, there is a huge underpenetrated opportunity for robotic surgery, and they are going to be the ones best positioned to capitalize on it over the next couple of years.”
FOR MORE INFORMATION ON THIS INTERVIEW CLICK HERE.
Peterson says that although Intuitive Surgical had a rough 2013 because of concerns over adverse events and outcomes, investors should keep a close eye on the company, which he believes is poised to grow this year. He says Intuitive Surgical has spent more than $700 million on research & development since launching its last product. A new product launch will be the key for Intuitive Surgical to reaccelerate growth, Peterson adds.
“We’re at the tip of the iceberg in terms of the market converting over to robotic surgery,” Peterson says. “They have managed to penetrate the prostate market and most of the hysterectomy market, but there are still opportunities in general surgery, so this is absolutely one I would be watching.”
The Robotic Surgery Platform
January 15, 2008